Burcon NutraScience Corporation
BRCNF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 106.9% | -49.3% | 112.2% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -228.3% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,949.3% | -3,655.7% | -2,002.1% | -4,421.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,167% | -4,039% | -6,969.9% | -5,982.6% |
| EPS Diluted | -1.06 | -0.061 | -0.23 | -0.095 |
| % Growth | -1,629.2% | 73.3% | -143.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |